IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 141 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.86 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $29,000 | -58.6% | 2,900 | -23.7% | 0.00% | – |
| Q3 2018 | $70,000 | -21.3% | 3,800 | -19.1% | 0.00% | – |
| Q2 2018 | $89,000 | +1171.4% | 4,700 | +840.0% | 0.00% | – |
| Q1 2018 | $7,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2017 | $7,000 | -61.1% | 500 | -58.3% | 0.00% | – |
| Q3 2017 | $18,000 | -91.0% | 1,200 | -88.7% | 0.00% | -100.0% |
| Q2 2017 | $200,000 | +81.8% | 10,600 | +63.1% | 0.00% | – |
| Q1 2017 | $110,000 | +161.9% | 6,500 | +132.1% | 0.00% | – |
| Q4 2016 | $42,000 | -60.7% | 2,800 | -58.8% | 0.00% | – |
| Q3 2016 | $107,000 | +296.3% | 6,800 | +300.0% | 0.00% | – |
| Q1 2015 | $27,000 | – | 1,700 | – | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q2 2014 | $17,000 | – | 1,100 | – | 0.00% | – |
| Q1 2014 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |